(XUEB) Xtrackers II USD Emerging - Ratings and Ratios
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Etf •
ISIN: LU1920015440
Government, Bonds, Emerging, Markets, Debt, Securities, Investments
Description: XUEB Xtrackers II USD Emerging
URL: http://www.dws.lu Index: Morningstar EM Sov Bd GR USD
Additional Sources for XUEB ETF
XUEB ETF Overview
| Market Cap in USD | 7m |
| Category | Global Emerging Markets Bond |
| TER | 0.26% |
| IPO / Inception | 2020-03-11 |
XUEB ETF Ratings
| Growth Rating | 5.84 |
| Fundamental | - |
| Dividend Rating | 0.0 |
| Rel. Strength | 2.36 |
| Analysts | - |
| Fair Price Momentum | 31.83 EUR |
| Fair Price DCF | - |
XUEB Dividends
Currently no dividends paidXUEB Growth Ratios
| Growth Correlation 3m | 25.1% |
| Growth Correlation 12m | -0.6% |
| Growth Correlation 5y | 18.1% |
| CAGR 5y | 0.18% |
| CAGR/Max DD 5y | 0.01 |
| Sharpe Ratio 12m | 0.01 |
| Alpha | -5.67 |
| Beta | 0.148 |
| Volatility | 88.29% |
| Current Volume | 0k |
| Average Volume 20d | 0k |
What is the price of XUEB shares?
As of July 06, 2025, the stock is trading at EUR 34.55 with a total of 4 shares traded.
Over the past week, the price has changed by +0.35%, over one month by -0.88%, over three months by -2.05% and over the past year by +0.29%.
As of July 06, 2025, the stock is trading at EUR 34.55 with a total of 4 shares traded.
Over the past week, the price has changed by +0.35%, over one month by -0.88%, over three months by -2.05% and over the past year by +0.29%.
Is Xtrackers II USD Emerging a good stock to buy?
Neither. Based on ValueRay´s Analyses, Xtrackers II USD Emerging is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 5.84 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XUEB is around 31.83 EUR . This means that XUEB is currently overvalued and has a potential downside of -7.87%.
Neither. Based on ValueRay´s Analyses, Xtrackers II USD Emerging is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 5.84 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XUEB is around 31.83 EUR . This means that XUEB is currently overvalued and has a potential downside of -7.87%.
Is XUEB a buy, sell or hold?
Xtrackers II USD Emerging has no consensus analysts rating.
Xtrackers II USD Emerging has no consensus analysts rating.
What are the forecasts for XUEB share price target?
According to our own proprietary Forecast Model, XUEB Xtrackers II USD Emerging will be worth about 34.6 in July 2026. The stock is currently trading at 34.55. This means that the stock has a potential upside of +0.03%.
According to our own proprietary Forecast Model, XUEB Xtrackers II USD Emerging will be worth about 34.6 in July 2026. The stock is currently trading at 34.55. This means that the stock has a potential upside of +0.03%.
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 34.6 | 0% |